Placebo's Brian Molko charged with defamation
Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.
Talazoparib + enzalutamide is linked to improved survival for patients with mCRPC unselected for HRR gene alterations.
Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression
Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS ...
Ivy is taking part in the five-year double-blind placebo controlled trial, meaning she doesn't know if she got the drug or ...
Compared with placebo, a preoperative and intraoperative infusion of tranexamic acid was associated with significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results